Affiliation:
1. National Medical Research Center of Cardiology
Publisher
Stolichnaya Izdatelskaya Kompaniyaizdat
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine
Reference7 articles.
1. Revishvili A.Sh., Shlyakhto E.V., Sulimov V.A. et al. Clinical practice guidelines on diagnosis and management of atrial fibrillation. Moscow: Russian society of arrhythmology; 2017. (In Russ.).
2. Roy D., Pratt C.M., Torp-Pedersen C. et al. for the Atrial Arrhythmia Conversion Trial Investigators. Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation. 2008;117:1518-25. doi:10.1161/CIRCULATIONAHA.107.723866.
3. Grönberg T., Hartikainen J.E., Nuotio I. et al. Can we predict the failure of electrical cardioversion of acute atrial fibrillation? The FinCV study. Pacing Clin Electrophysiol. 2015;38(3):368-75. doi:10.1111/pace.12561.
4. Glushkov R.G., Yuzhakov S.D., Lvov A.I. et al. New group of class III antiarrihytmic drugs - derivations of piperidil-4-ethane. Journal of Pharmaceutical Chemistry. 2011;45(2):3-12 (In Russ.).
5. Rosenstraukh L.V., Fedorov V.V., Reznik A.V. et al. Assessment of electrophysiologic effects of class III antiarrhythmic drug RG-2 in experimental study. Kardiologiia 2003;9:56-64 (In Russ.).
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献